Multiple IV Dose Study Of PF-04360365 In Patients With Mild To Moderate Alzheimer's Disease
Public ClinicalTrials.gov record NCT00722046. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 2 MULTICENTER, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED STUDY OF THE SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF MULTIPLE DOSES OF PF 04360365 IN PATIENTS WITH MILD TO MODERATE ALZHEIMER'S DISEASE.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Purpose of the study is to determine whether multiple dose administration of PF-04360365 is safe and well tolerated in patient with mild to moderate Alzheimer's disease.
Study identification
- NCT ID
- NCT00722046
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 198 participants
Conditions and interventions
Conditions
Interventions
- PF-04360365 0.1 mg/kg Biological
- PF-04360365 0.5 mg/kg Biological
- PF-04360365 1 mg/kg Biological
- Placebo Drug
- PF-04360365 3 mg/kg Biological
- PF-04360365 8.5 mg/kg Biological
Biological · Drug
Eligibility (public fields only)
- Age range
- 50 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 5, 2008 (Actual)
- Primary completion
- Aug 16, 2011 (Actual)
- Completion
- Aug 16, 2011 (Actual)
- Last update posted
- Nov 7, 2022
2008 – 2011
United States locations
- U.S. sites
- 15
- U.S. states
- 6
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pivotal Research Center | Peoria | Arizona | 85381 | — |
| Sun Radiology- for MRI | Peoria | Arizona | 85381 | — |
| Dedicated Phase 1 | Phoenix | Arizona | 85013 | — |
| Neuroscience Consultants, LLC | Miami | Florida | 33176 | — |
| Miami Research Associates | South Miami | Florida | 33143 | — |
| MRA Clinical Research | South Miami | Florida | 33143 | — |
| Sleep Florida, LLC | South Miami | Florida | 33143 | — |
| Alexian Brothers Medical Center | Elk Grove Village | Illinois | 60007 | — |
| Alexian Brothers Neurosciences Institute | Elk Grove Village | Illinois | 60007 | — |
| Stark Pharmacy | Overland Park | Kansas | 66209 | — |
| Vince and Associates Clinical Research | Overland Park | Kansas | 66211 | — |
| Vince and Associates Clinical Research | Overland Park | Kansas | 66212 | — |
| Memory Enhancement Center of America, Inc | Eatontown | New Jersey | 07724 | — |
| Central Jersey Radiology | Oakhurst | New Jersey | 07755 | — |
| Butler Hospital | Providence | Rhode Island | 02906 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 27 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00722046, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 7, 2022 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00722046 live on ClinicalTrials.gov.